Synapse Technologies Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $15.3M

Synapse Technologies General Information

Description

Operator of a biotechnology company intended to deliver therapeutic enzymes and other drugs. The company specializes in the research and development of technologies for therapeutic drug delivery across the blood-brain barrier.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 6660 NorthWest Marine Drive
  • Vancouver, British Columbia V6T 1Z4
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synapse Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Mar-2002 $15.3M 000 000.00 Completed Clinical Trials - General
2. Later Stage VC 12-Jan-2000 000 000 Completed Startup
1. Spin-Off 01-Jan-1992 Completed Startup
To view Synapse Technologies’s complete valuation and funding history, request access »

Synapse Technologies Patents

Synapse Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-0479898-B1 Electrical connection between a first connector and a second one insertable in the first one Inactive 29-Jun-1989 000000000
CA-2063251-C Cam actuated electrical connector Inactive 29-Jun-1989 000000000
EP-0479898-A1 Cam actuated electrical connector. Active 29-Jun-1989 000000000 0
EP-0479898-A4 Cam actuated electrical connector Active 29-Jun-1989 H01R12/79 0

Synapse Technologies Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BDC Capital Growth/Expansion Minority 000 0000 000000 0
BMO Financial Group Corporation Minority 000 0000 000000 0
FutureFund Capital Venture Capital Minority 000 0000 000000 0
GrowthWorks Venture Capital Minority 000 0000 000000 0
MDS Ventures Pacific PE-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Synapse Technologies FAQs

  • When was Synapse Technologies founded?

    Synapse Technologies was founded in 1992.

  • Where is Synapse Technologies headquartered?

    Synapse Technologies is headquartered in Vancouver, Canada.

  • What industry is Synapse Technologies in?

    Synapse Technologies’s primary industry is Biotechnology.

  • Is Synapse Technologies a private or public company?

    Synapse Technologies is a Private company.

  • What is the current valuation of Synapse Technologies?

    The current valuation of Synapse Technologies is 000.00.

  • What is Synapse Technologies’s current revenue?

    The current revenue for Synapse Technologies is 000000.

  • How much funding has Synapse Technologies raised over time?

    Synapse Technologies has raised $6M.

  • Who are Synapse Technologies’s investors?

    BDC Capital, BMO Financial Group, FutureFund Capital, GrowthWorks, and MDS Ventures Pacific are 5 of 8 investors who have invested in Synapse Technologies.

  • When was Synapse Technologies acquired?

    Synapse Technologies was acquired on 21-Mar-2002.

  • Who acquired Synapse Technologies?

    Synapse Technologies was acquired by BioMarin Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »